KOSPICosmetics214420

Tonymoly

₩3,950▲ 0.89%2026-11-18 close
Market Cap
₩95B
Turnover
₩100M
Volume
30K
Shares out.
24.1M
PER
11.3×
PBR
0.8×
EPS
₩346
Dividend Yield
1.28%

PER, EPS, PBR and BPS are calculated in-house from the last 4 quarters (2025Q4–2026Q3) · Dividend yield is based on ₩50 per share · Prices as of the 2026-11-18 close

01

Report overview

Export and ODM Growth Still Waits on Profit Recovery

Tonymoly grew sales and operating profit through 2025, but controlling-shareholder net profit has fallen for two straight quarters, leaving whether overseas exports and ODM growth reach earnings as the central question.

  1. 1

    Revenue reached KRW 220.3 billion in 2025, the largest year in the 2022–2025 span, and has risen for three consecutive years since 2023.

  2. 2

    Operating profit turned to KRW 9.62 billion in 2023 and rose for two straight years to KRW 14.4 billion in 2025, while the operating margin eased from 6.8% to 6.5%.

  3. 3

    Net profit attributable to controlling shareholders was KRW 11.1 billion in 2025, down 32.0% from the prior year, and has declined in each of the two quarters after its 2026 first-quarter peak of KRW 3.54 billion.

  4. 4

    Overseas exports grew led by the United States, but a May 2026 research note from a Korean securities firm cut its 2026 earnings estimates on weaker short-term US export sales.

  5. 5

    The next checkpoints are the 2026 annual report and first-quarter 2027 results, where US export recovery and a rebound in controlling-shareholder profit can be checked.

02

Business structure

Tonymoly manufactures and sells cosmetics and also runs an original design manufacturing (ODM) business through its subsidiaries. Its ODM subsidiary, in which Tonymoly holds a 100% stake, was cited by brokers in early 2025 as a contributor to the group's subsidiary results.

Distribution is shifting away from its own offline stores toward new channels such as Daiso, health and beauty (H&B) stores, and PX discount marts. The company runs a Daiso-exclusive brand, BONCEPT, and an E-Mart-exclusive brand, Dermatician, to tailor portfolios by channel.

Overseas it has expanded into the United States, Hong Kong, Europe, Mexico and Australia, and it has a medium-term supply contract with a Japanese trading house for Japan.

In the third quarter of 2025, a securities report said domestic cosmetics sales on a standalone basis rose 12% year on year while exports grew 44% on strong US demand. Standalone 2025 revenue was KRW 141.4 billion, and the gap to consolidated revenue of KRW 220.3 billion reflects subsidiary results.

Among Korean road-shop brands, a May 2026 report described Tonymoly's growth as the most stable, while peers such as Able C&C were still seeing slow revenue recovery.

03

Earnings trend

Quarterly revenue · Operating profit
RevenueOperating profit
Annual revenue · Operating profit
RevenueOperating profit
Quarterly results · Last 5 quarters
QuarterRevenueOperating profitOp. margin
2025Q3₩56.3B₩4.3B7.7%
2025Q4₩52.6B₩800M1.5%
2026Q1₩52B₩4.2B8.0%
2026Q2₩54B₩2.3B4.2%
2026Q3₩56.2B₩3.1B5.6%
Annual results
YearRevenueOperating profitNet income (parent)Op. marginROEDebt-to-equity
2022₩126.7B-₩7.3B-₩81,590,565−5.7%−0.1%104.4%
2023₩151.1B₩9.6B₩3.7B6.4%3.9%99.9%
2024₩177B₩12.1B₩16.4B6.8%14.9%80.4%
2025₩220.3B₩14.4B₩11.1B6.5%9.4%81.1%

Consolidated basis (financial statements including subsidiaries) · Final figures from DART filings · Net income attributable to owners of the parent · Data as of 2026-11-17

04

Earnings analysis

On a reported basis, consolidated revenue rose from KRW 126.7 billion in 2022 to KRW 151.1 billion in 2023 (up 19.2% year on year), KRW 177 billion in 2024 (up 17.1%) and KRW 220.3 billion in 2025 (up 24.5%), making 2025 the largest year of the 2022–2025 span.

Operating profit moved from an operating loss of KRW 7.26 billion in 2022 to a KRW 9.62 billion profit in 2023, then rose to KRW 12.1 billion in 2024 (up 25.8%) and KRW 14.4 billion in 2025 (up 18.7%), growing for two consecutive years.

The operating margin stayed in the mid-6% range, moving from -5.7% in 2022 to 6.4%, 6.8% and 6.5% in 2023, 2024 and 2025, so margin expansion lagged revenue growth.

Net profit attributable to controlling shareholders swung from a loss of KRW 81.59 million in 2022 to KRW 3.7 billion in 2023, jumped to KRW 16.4 billion in 2024 (up 342.0%) and fell to KRW 11.1 billion in 2025 (down 32.0%).

Net profit including non-controlling interests fell in the same direction, from KRW 16.6 billion in 2024 to KRW 11.4 billion in 2025. At the end of 2025, total equity was KRW 125.1 billion, of which KRW 118 billion belonged to controlling shareholders, and total liabilities were KRW 101.5 billion.

The debt ratio fell from 104.4% in 2022 to 80.4% in 2024 and 81.1% in 2025. Operating cash flow stayed near KRW 9 billion to KRW 10 billion a year over 2022–2025.

Quarterly revenue peaked at KRW 56.3 billion in the third quarter of 2025, dipped to KRW 52.6 billion in the fourth quarter (down 6.6% quarter on quarter) and KRW 52 billion in the first quarter of 2026 (down 1.0%), then recovered to KRW 54 billion in the second quarter (up 3.7%) and KRW 56.2 billion in the third quarter (up 4.1%), which was still down 0.2% year on year.

Operating profit fell to KRW 794 million in the fourth quarter of 2025 (down 81.7%), rebounded to KRW 4.17 billion in the first quarter of 2026 (up 425.0%), then dropped to KRW 2.26 billion in the second quarter and was KRW 3.13 billion in the third quarter (down 27.8% year on year).

Net profit attributable to controlling shareholders peaked at KRW 3.54 billion in the first quarter of 2026, then declined for two quarters to KRW 1.29 billion and KRW 634 million, down 82.5% year on year in the third quarter. The sum for the latest four quarters was KRW 8.26 billion.

05

Industry analysis

Cosmetics distribution is in the middle of a structural shift from domestic road-shop stores toward new channels such as Daiso and health and beauty stores.

A securities analysis of the first quarter of 2025 noted that Tonymoly's domestic road-shop sales fell 21% year on year while growth in new channels offset much of the decline in its domestic business.

Overseas, US exports drove growth, while a late-2025 securities report described cosmetics demand in China and Japan, Tonymoly's established export markets, as shrinking.

A May 2026 note cut near-term estimates on weak US exports but kept its view that medium-term overseas growth and ODM earnings momentum remain intact. An October 2026 report from a Korean securities firm described 2026 as a transition year in which visible results from overseas operations are the key variable.

Among road-shop peers, Able C&C was cited as still showing slow revenue recovery. Tonymoly's position is that of a company that moved early from road-shop stores toward new channels.

Its operating margin of roughly 6.5% remains well below the level of the larger listed cosmetics makers, which is a comparison the reported figures support.

06

Outlook

On the brokerage side, a May 2026 note from a Korean securities firm cut its 2026 earnings estimates on weaker short-term US exports, set a target price of KRW 9,000, and kept its Buy rating, while still citing medium-term cosmetics export growth and ODM earnings momentum as positives.

An October 2026 report from another Korean securities firm gave no rating and target and called 2026 a transition year in which visible results from overseas operations are the key variable.

Consensus estimates as of March 2026 sat well above the reported second-quarter 2026 operating profit, which came in at KRW 2.26 billion, down 59% year on year. The ODM subsidiary has been reported to be phasing in automated production equipment since 2025.

In new channels, the key question is whether sales through the Daiso-exclusive brand and health and beauty stores continue to grow after 2026. The 2026 annual report will disclose full-year revenue mix and regional breakdowns, so whether the operating margin exceeds 2025's 6.5% is the next checkpoint.

The first-quarter 2027 results will show whether US exports recover and whether controlling-shareholder net profit returns toward the KRW 3.54 billion recorded in the first quarter of 2026.

07

Valuation

PER
11.3×
PBR
0.8×
ROE
7.0%
EPS
₩346
BPS
₩5,112
Dividend per share
₩50

Valuation has to be read alongside the earnings trend and the asset base. Market capitalization sits below the controlling-shareholder equity recorded at the end of 2025, so the price-to-book ratio is below 1x. The price-to-book ratio has moved lower since the end of 2025 on a quarter-end basis.

The dividend yield is below the average for the KOSPI chemicals sector. On earnings, controlling-shareholder net profit fell in 2025 and has declined in the latest quarters, so multiples read differently depending on whether they are based on past or current earnings.

On brokerage estimates the multiple looks lower, but if actual profit falls short of those estimates, the same share price implies a higher multiple. Compared with its past price-to-book range, the stock now trades at a smaller premium to net assets.

Equity grew to KRW 125.1 billion, and the debt ratio fell to 81.1% from 104.4% in 2022, which are factual markers of balance sheet strength.

PER, EPS, PBR and BPS are all calculated in-house (the same method as Naver and Toss) · Dividend yield = cash dividend per share from DART filings (supplemented by KRX) ÷ current price · As of 2026-11-17

08

Bull factors

Export growth led by the United States

A securities report said overseas exports on a standalone basis rose 44% year on year in the third quarter of 2025, supported by strong US demand. The same report argued that growth in the United States and other regions could offset declines in established markets such as China and Japan. A larger overseas share could absorb some of the volatility in domestic channels.

Three years of revenue growth from new channels

Revenue of KRW 220.3 billion in 2025 marked three consecutive annual increases since 2023. A May 2026 report pointed to expansion in Daiso, health and beauty stores and PX discount marts as the driver of that growth. The company is also reducing its own offline stores, which changes its distribution cost structure.

ODM subsidiary and a stronger balance sheet

Its wholly owned ODM subsidiary has been winning orders from export-led brands as well as from Tonymoly itself, according to a securities report. The debt ratio fell from 104.4% in 2022 to 81.1% in 2025, and total equity at the end of 2025 was KRW 125.1 billion. A larger equity base gives the company more room to absorb external shocks.

09

Bear factors

Consecutive declines in quarterly profit

The decline in operating profit came even as revenue recovered, because profit did not follow. Net profit attributable to controlling shareholders was KRW 634 million, down 82.5% year on year, and it has declined for two quarters after peaking at KRW 3.54 billion in the first quarter of 2026. Revenue has recovered, but profit has not followed.

Weaker US exports and lower estimates

A May 2026 note from a Korean securities firm cut its 2026 earnings estimates on weaker short-term US exports and lowered its target price from KRW 10,500 to KRW 9,000. The firm kept its Buy rating, but the target cut followed from the lower earnings estimates. Other coverage has also said US exports have not grown as much as expected.

Flat margins and shrinking road-shop sales

The operating margin moved between 6.4% and 6.8% from 2023 to 2025, trailing revenue growth. A securities analysis of the first quarter of 2025 said domestic road-shop sales fell 21% year on year. If new channels do not fully offset declines in legacy channels, margin improvement could be delayed.

10

Risk factors

Concentration in export markets

Overseas growth leans heavily on US exports, so swings in US orders flow directly into results. Cosmetics demand in China and Japan has been described as shrinking, which could delay recovery in established markets. Reliance on a few regions and buyers can amplify earnings volatility.

Channel transition costs and road-shop decline

Shifting from owned offline stores to Daiso and health and beauty stores may create profitability gaps between channels. If sales through new channels do not keep up, they will not offset road-shop declines. Whether the channel shift lifts margins needs to be checked in the 2026 annual report.

Earnings volatility and reliance on subsidiaries

Net profit attributable to controlling shareholders fell from KRW 16.4 billion in 2024 to KRW 11.1 billion in 2025, and quarterly results have swung sharply. Operating profit in the fourth quarter of 2025 was KRW 794 million, down 81.7% from the prior quarter. As the ODM subsidiary's share of profit grows, changes in its orders pass directly through to group results.

11

What to watch next

  1. Around late February 2027

    Full-year 2026 preliminary results, based on last year's schedule when fourth-quarter preliminary results were released on February 27, 2026. The check is whether fourth-quarter operating profit recovers from the KRW 794 million recorded in the fourth quarter of 2025.

  2. By the end of March 2027

    Filing of the 2026 annual report. It will disclose full-year revenue mix and regional breakdowns; whether the operating margin exceeds 2025's 6.5% and the trend in the debt ratio are the key items.

  3. Around mid-May 2027

    First-quarter 2027 results, timed on last year's pattern when first-quarter 2026 results came out on May 15, 2026. The checks are whether US exports recover and whether controlling-shareholder net profit returns toward KRW 3.54 billion.

  4. Around mid-August 2027

    Second-quarter 2027 results, timed on the August 14, 2026 disclosure of second-quarter 2026 results. The checks are how much new-channel sales and ODM subsidiary revenue grew in the quarter.

12

Overall view

Tonymoly moved from an operating loss in 2022 to a profit in 2023, and through 2025 it recorded three consecutive years of revenue growth and two consecutive years of operating profit growth. The debt ratio fell from 104.4% in 2022 to 81.1% in 2025, and total equity rose to KRW 125.1 billion.

Net profit attributable to controlling shareholders, however, fell from KRW 16.4 billion in 2024 to KRW 11.1 billion in 2025, and has declined for two quarters after peaking at KRW 3.54 billion in the first quarter of 2026. Third-quarter 2026 operating profit was KRW 3.13 billion, down 27.8% year on year.

Overseas exports grew 44% led by the United States in the third quarter of 2025, but a May 2026 securities report cut estimates on weaker short-term US exports. New-channel expansion supported revenue, yet the operating margin has stayed in the mid-6% range.

Both positive and negative factors are present, and which side prevails will be shown by upcoming results. The next checkpoints are the operating margin in the 2026 annual report and whether US exports recover in the first quarter of 2027 results.

13

Sources

  1. Korea Exchange (KRX) — Prices · Market Cap · Volume
  2. FSS electronic disclosure system (DART) — Financial statements · Dividend filings
Show 16 more articles and sources
  1. vegannews.co.kr
  2. investing.com
  3. investing.com
  4. thinkpool.com
  5. topdaily.kr
  6. comp.wisereport.co.kr
  7. m.thinkpool.com
  8. jasoseol.com
  9. m.thinkpool.com
  10. comp.fnguide.com
  11. news.nate.com
  12. m.news.nate.com
  13. kr.investing.com
  14. dailyinvest.kr
  15. m.thinkpool.com
  16. businesspost.co.kr

Report written 2026-11-18 · Data as of 2026-11-17

This content is AI analysis of market data and web search results, provided for information only. It is not a solicitation or recommendation to invest. Investment decisions and their consequences are the investor's own responsibility. Data may be delayed or contain errors.

Other reports in this industry

View industry analysis